Nodal peripheral T-cell lymphoma with TFH phenotype
Clinical trials for Nodal peripheral T-cell lymphoma with TFH phenotype explained in plain language.
Never miss a new study
Get alerted when new Nodal peripheral T-cell lymphoma with TFH phenotype trials appear
Sign up with your email to follow new studies for Nodal peripheral T-cell lymphoma with TFH phenotype, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to boost remission in tough lymphoma
Disease control Recruiting nowThis phase II trial tests whether adding either duvelisib or oral azacitidine to standard chemotherapy improves outcomes for people with certain types of peripheral T-cell lymphoma that have not been treated yet. About 170 participants will receive one of three treatment combinat…
Matched conditions: NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE
Phase 2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill shows promise in Hard-to-Treat blood cancer
Disease control Recruiting nowThis phase 3 trial tests a new oral drug, soquelitinib, against standard single-agent chemotherapy in 150 adults with relapsed or refractory peripheral T-cell lymphoma. The study aims to see if soquelitinib can delay cancer progression better than current options. Participants ar…
Matched conditions: NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE
Phase 3 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Massive T-Cell lymphoma database aims to unlock new insights
Knowledge-focused Recruiting nowThis study is creating a large database of information and tissue samples from 1,000 people with T-cell lymphoma. Researchers will use this data to learn more about the disease and how to improve patient outcomes. Participants provide medical information and optional blood and na…
Matched conditions: NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC